Clinical trial
FibroLamellar Carcinoma: an International Registry Study
NCT05730686 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FibroLamellar Carcinoma: an International Registry Study
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 15, 2023
- Completion date
- February 28, 2025
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
fibrolamellar cancer of the liver